4512 — Wakamoto Pharmaceutical Co Balance Sheet
0.000.00%
- ¥10bn
 - ¥8bn
 - ¥8bn
 
- 26
 - 36
 - 26
 - 15
 
Annual balance sheet for Wakamoto Pharmaceutical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st  | 2022 March 31st  | 2023 March 31st  | 2024 March 31st  | 2025 March 31st  | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — | 
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho | 
| Standards: | JAS | JAS | JAS | JAS | JAS | 
| Status: | Final | Final | Final | Final | Final | 
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 2,844 | 3,232 | 3,879 | 3,665 | 2,955 | 
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2,709 | 2,811 | 3,214 | 2,875 | 2,627 | 
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 7,638 | 8,608 | 9,353 | 8,970 | 8,908 | 
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 3,527 | 3,297 | 3,032 | 3,028 | 3,313 | 
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 14,572 | 14,953 | 15,712 | 15,421 | 15,003 | 
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,713 | 2,009 | 2,239 | 1,808 | 2,035 | 
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 3,187 | 3,473 | 3,805 | 3,395 | 3,392 | 
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 11,386 | 11,481 | 11,907 | 12,026 | 11,610 | 
| Total Liabilities & Shareholders' Equity | 14,572 | 14,953 | 15,712 | 15,421 | 15,003 | 
| Total Common Shares Outstanding |